Forgot your password?
Sanofi and Regeneron’s monoclonal antibody (mAb) Dupixent (dupilumab) met all primary and key secondary endpoints in a phase 3 trial for the chronic infammatory skin disease prurigo nodularis.
The New England Journal of Medicine has published results from its PSOARING 1 and PSOARING 2 pivotal trials for its investigational drug tapinarof topical cream, a novel, steroid-free, therapeutic aryl hydrocarbon receptor (AhR) modulating agent under development for the treatment of plaque psoriasis in adults.
A global survey, presented at the European Academy of Dermatology and Venereology (EADV) congress, has revealed the impact of atopic dermatitis (AD) on children and teenagers.
Findings from a pilot study show that a new prototype portable device that can be used to treat basal cell carcinoma at home signifcantly reduce pain levels while achieving efcacy comparable with a hospital stay.
A national review has found that individuals using topical steroids for long periods of time can sufer severe skin withdrawal side efects.
For the frst time, the National Institute for Health and Care Excellence (NICE) has recommended mental health support for people severely afected by their acne.
A new survey has shown that almost half of people in Europe over the aged of 18 years have reported at least one skin problem or disease in the past 12 months.
The awards took place at the Reading office of our sponsor, Sanofi Genzyme, and were presented by Dr Hilary Jones.
OBE awarded for his services to the national COVID-19 response
The guideline is the first from NICE to recommend mental health support for people with acne experiencing psychological distress